1. Home
  2. ICUI

as of 03-02-2026 3:30pm EST

$146.10
$3.11
-2.08%
Stocks Health Care Medical/Dental Instruments Nasdaq

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Founded: 1984 Country:
United States
United States
Employees: N/A City: SAN CLEMENTE
Market Cap: 3.9B IPO Year: 1995
Target Price: $182.25 AVG Volume (30 days): 272.9K
Analyst Decision: Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.03 EPS Growth: 100.62
52 Week Low/High: $107.02 - $160.29 Next Earning Date: 05-22-2026
Revenue: $2,231,262,000 Revenue Growth: -6.33%
Revenue Growth (this year): -1.54% Revenue Growth (next year): 4.10%
P/E Ratio: 4973.67 Index: N/A
Free Cash Flow: 91.8M FCF Growth: -26.36%

AI-Powered ICUI Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 59.32%
59.32%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest ICU Medical Inc. News

ICUI Breaking Stock News: Dive into ICUI Ticker-Specific Updates for Smart Investing

All ICUI News

Share on Social Networks: